Recent Advances in the Treatment Of Newly Diagnosed Multiple Myeloma

Edward Libby, MD, and Josh Epworth, ARNP, interpreted data on current and novel treatments, discussed how to select initial therapy based on patient risk and in alignment with guidelines and best practices, and evaluated the use of minimal residual disease testing in patients with multiple myeloma.

Detalles Bibliográficos
Autores principales: Libby, Edward, Epworth, Josh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2020
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857329/
https://www.ncbi.nlm.nih.gov/pubmed/33598330
http://dx.doi.org/10.6004/jadpro.2020.11.3.17
_version_ 1783646426894434304
author Libby, Edward
Epworth, Josh
author_facet Libby, Edward
Epworth, Josh
author_sort Libby, Edward
collection PubMed
description Edward Libby, MD, and Josh Epworth, ARNP, interpreted data on current and novel treatments, discussed how to select initial therapy based on patient risk and in alignment with guidelines and best practices, and evaluated the use of minimal residual disease testing in patients with multiple myeloma.
format Online
Article
Text
id pubmed-7857329
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Harborside Press LLC
record_format MEDLINE/PubMed
spelling pubmed-78573292021-02-16 Recent Advances in the Treatment Of Newly Diagnosed Multiple Myeloma Libby, Edward Epworth, Josh J Adv Pract Oncol Meeting Reports Edward Libby, MD, and Josh Epworth, ARNP, interpreted data on current and novel treatments, discussed how to select initial therapy based on patient risk and in alignment with guidelines and best practices, and evaluated the use of minimal residual disease testing in patients with multiple myeloma. Harborside Press LLC 2020-04 2020-04-01 /pmc/articles/PMC7857329/ /pubmed/33598330 http://dx.doi.org/10.6004/jadpro.2020.11.3.17 Text en © 2020 Harborside™ http://creativecommons.org/licenses/by-nc-nd/3.0/ This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Reports
Libby, Edward
Epworth, Josh
Recent Advances in the Treatment Of Newly Diagnosed Multiple Myeloma
title Recent Advances in the Treatment Of Newly Diagnosed Multiple Myeloma
title_full Recent Advances in the Treatment Of Newly Diagnosed Multiple Myeloma
title_fullStr Recent Advances in the Treatment Of Newly Diagnosed Multiple Myeloma
title_full_unstemmed Recent Advances in the Treatment Of Newly Diagnosed Multiple Myeloma
title_short Recent Advances in the Treatment Of Newly Diagnosed Multiple Myeloma
title_sort recent advances in the treatment of newly diagnosed multiple myeloma
topic Meeting Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857329/
https://www.ncbi.nlm.nih.gov/pubmed/33598330
http://dx.doi.org/10.6004/jadpro.2020.11.3.17
work_keys_str_mv AT libbyedward recentadvancesinthetreatmentofnewlydiagnosedmultiplemyeloma
AT epworthjosh recentadvancesinthetreatmentofnewlydiagnosedmultiplemyeloma

Ejemplares similares